TRT & TBI:

The Pea-Sized Problem

The pituitary gland is about the size of a pea. It sits at the base of your brain, connected by a thin stalk, cradled in a small pocket of bone. It controls testosterone, growth hormone, cortisol, thyroid hormones, and several others. It's the master switch for your entire hormone system.

It's also in one of the worst possible locations for someone who gets hit in the head.

In a concussion, the head whips fast and the brain shifts inside the skull. The pituitary, held by its stalk to the hypothalamus above and the bone below, gets sheared. The stalk can stretch, the blood supply can get cut off, and the gland can swell against the bone around it. One bad hit can damage it. Repeated hits make it worse.

Doctors call it post-traumatic hypopituitarism. The real-world version is a contact sport athlete who can't figure out why he's exhausted, foggy, depressed, losing muscle, sleeping like garbage, and has no sex drive, all years after the last concussion.

The Numbers

The most-cited figure comes from a systematic review and meta-analysis published in JAMA in 2007, covering 19 studies and 1,137 patients across TBI and aneurysmal subarachnoid hemorrhage. It found a pooled prevalence of 27.5% for hypopituitarism in the chronic phase after TBI (95% CI 22.8–28.9%).^[8]

Two things to hold onto about that number. The underlying studies were heterogeneous, using different tests and different diagnostic thresholds, so the pooled figure is an estimate rather than a hard rate. And prevalence ran higher after severe TBI than after mild or moderate injury. This is a real and common complication, but it is not a flat one-in-four risk from any knock to the head.

A 2019 cross-sectional study surveyed 3,409 former NFL players.^[7] Worth knowing up front how it was measured: the study did not draw blood. It asked whether a medical provider had ever recommended or prescribed medication for low testosterone or for erectile dysfunction, and used those answers as indicators.

The association was monotonic. Each step up in reported concussion symptoms came with higher odds of reporting a low-testosterone indicator, and even players with relatively few symptoms had significantly elevated odds. What the study does not show is testosterone falling as concussions accumulate. Nobody measured a level. It is a strong association in self-reported data, which is a different claim than a measured decline, and the difference matters if you want this to survive scrutiny.

Of the former players reporting low-testosterone indicators, 39.8% were currently taking medication for it. The other 60% were not.

What Testosterone Does for the Brain

Testosterone isn't just a muscle hormone. In the brain, it drives several processes that matter directly after injury:

• Glucose metabolism. The brain runs on glucose. Testosterone improves how well brain cells take it up and use it. Low T means the brain is trying to heal on reduced fuel.
• Synaptic plasticity. This is the brain's ability to form and strengthen connections between neurons. It's how we learn, remember, and recover after injury. Testosterone supports it directly.
• Antioxidant defenses. TBI floods the brain with oxidative stress that damages cells. Testosterone boosts the brain's own defenses to counter it.
• Neurogenesis. This is the creation of new neurons. Adult brains can make new ones, especially in the hippocampus, and testosterone promotes it.
• Cell survival. Damaged brain cells have a built-in kill switch. Testosterone helps injured neurons hang on instead of self-destructing, keeping that switch from firing.

When testosterone crashes after TBI, every one of those processes slows down. Your brain is trying to recover from injury with one of its most important repair systems running on fumes.^[6]

The Wayne State Study

In November 2025, a Wayne State University team published work in the American Journal of Physiology: Heart and Circulatory Physiology looking at how brain injury changes the body's stress response.^[1] This one gets misquoted, so here is what it actually was: a study in mice, examining chloride/bicarbonate exchange and cardiovascular reactivity after injury. Testosterone given after the injury reduced the excessive cardiovascular stress response the injured animals otherwise showed.

That is a mechanistic finding in an animal model, and it points somewhere worth investigating in humans. It is not a study of concussed athletes, and it did not measure testosterone falling in anyone who trains hard.

The first author was Jack Summers, a medical student at Wayne State who started the project as an undergraduate while competing in NCAA Division I ice hockey. A contact sport athlete studying what contact sports do to the endocrine system. The senior author, Dr. Warren Lockette, framed the clinical gap this way:

Healthcare providers often overlook the connection between sports concussions and low testosterone syndrome. — Dr. Warren Lockette, Wayne State University

That is his read on clinical practice, offered as context alongside the paper. Treat it as an expert's opinion about what gets missed in clinic, not as an output of the mouse experiment.

What Human Trials Have Actually Found

Very little, and it is important to be straight about that.

There is one randomized controlled trial of testosterone therapy in TBI. Craig Hospital in Colorado, one of the top TBI rehab centers in the country, ran a double-blind, placebo-controlled pilot study of transdermal testosterone gel in hypogonadal men during inpatient rehabilitation. It began in 2010 and the results were published in NeuroRehabilitation in 2020.^[3] This is a completed study, not an ongoing one, and it is the same study you will see referenced secondhand as promising early evidence.

The scale is the story. Of 498 men screened, 70 enrolled and only 22 were randomized: 12 to testosterone, 10 to placebo. That is a very small trial with heavy attrition, and it was not powered to establish efficacy.

On its primary endpoint, rate of functional improvement on the FIM scale, there was no significant difference between groups (p=0.76 for intercepts, p=0.55 for slopes). The testosterone group did show the greatest absolute improvement in FIM scores and grip strength, and there was no difference in adverse events. Grip strength improved 19.5 lbs in the testosterone group against 14.8 lbs on placebo. A separate untreated group with normal testosterone improved 5.5 lbs.^[2]

The 2023 systematic review that covers this literature reached the obvious conclusion: it is difficult to draw conclusions about testosterone therapy in men with TBI from the evidence available.^[2] One underpowered pilot trial is where the human evidence begins and ends.

The animal work is more encouraging. Testosterone reduces mitochondrial dysfunction and neurodegeneration after TBI in rodent models,^[6] and restores vestibular function in repetitive mild TBI models.^[5] The mechanism is plausible and the preclinical signal is real. The human trial data to match it does not exist yet, and plenty of compounds that looked good in mice went nowhere in people.

The Screening That Rarely Gets Ordered

Here's what kills me about this. The symptoms of post-TBI hormonal dysfunction overlap almost completely with post-concussion syndrome: fatigue, brain fog, depression, sleep disruption, difficulty concentrating, reduced motivation, muscle loss, weight gain. If you walk into a doctor's office with a concussion history and those symptoms, you get told "that's your brain injury." You might get a referral to a neurologist. Maybe neuropsych testing. Maybe antidepressants.

What you almost certainly don't get is a hormone panel.

Guidance here is more targeted than "everybody get a panel." Chronic-phase screening is generally considered at around three to six months post-injury for people who were hospitalized longer than 48 hours, or who have ongoing symptoms that fit hypopituitarism. Universal hormone screening after every concussion is not recommended, and I am not going to pretend otherwise to make the point land harder. The Concussion Alliance flags hormonal dysfunction as a long-term issue requiring proactive testing, because it will not surface in a standard post-concussion evaluation on its own.^[4]

The other correction worth making is to this article's own framing. Testosterone gets the headline because it is the one people have heard of, but the pituitary runs cortisol, thyroid, growth hormone, the gonadotropins, and water regulation. Adrenal insufficiency from a damaged pituitary is the one that can actually put you in hospital. If the concern is a pituitary that took a hit, the question for a clinician is whether a broader pituitary evaluation makes sense, not whether you should start TRT.

With those boundaries in place, the gap is still real. In the NFL data, 60% of former players reporting low-testosterone indicators were not on any treatment for it. Some of that is people who declined treatment or did not need it. Some of it is men managing what they were told were permanent post-concussion symptoms, who were never evaluated for a contributor that is identifiable with blood work.

The Enclomiphene Alternative

There's a second route that gets less attention than testosterone injections, and it fits the TBI picture in an interesting way. TBI rarely damages the testes themselves. The problem is upstream, in the pituitary signal that tells them to produce. Doctors call that secondary hypogonadism, and it's exactly the problem enclomiphene was built to solve.^[10]

Standard TRT adds testosterone from the outside. That raises your levels, but it also tells your body to stop making its own, which shrinks the testes and shuts down fertility. Enclomiphene takes the opposite approach. It blocks estrogen's feedback signal at the pituitary, so the pituitary sends out more LH and FSH, which tells the testes to make more testosterone on their own. You keep your own production running instead of replacing it.^[9]

The number that gets quoted comes from a retrospective single-center review at one andrology clinic, covering 66 patients over two years. Enclomiphene raised total testosterone by a median of 166 ng/dL, against 98 ng/dL for clomiphene. That difference was not statistically significant (p=0.20), so enclomiphene did not outperform the older, cheaper drug on the measure people quote it for. Where it did separate was estradiol control and tolerability: estradiol fell 5.92 pg/mL on enclomiphene versus a 17.50 pg/mL rise on clomiphene (p=0.001), and adverse effects ran 13.8% against 47%.^[9]

Three caveats, and they matter more than the headline number. No TBI patients were in that study, and there are no trials of enclomiphene in TBI at all. The mechanism lines up with secondary hypogonadism, which is the pattern TBI tends to produce, but a mechanism that lines up is a hypothesis, not a recommendation, and how well it could work would depend on how much functioning pituitary survived the injury. And it is not FDA-approved for any use. Development was discontinued in 2021 after the FDA repeatedly declined the application, so it reaches people only through compounding pharmacies on a prescription. It is also illegal to sell as a supplement ingredient, which has not stopped it from turning up on testosterone-booster labels.^[12]

The accurate framing: enclomiphene is an investigational, off-label, fertility-preserving option that a clinician might consider for selected cases of confirmed secondary hypogonadism. It is not a DarkWolf-endorsed alternative to TRT, and it has never been tested for what this article is about.

Field Report: What I Found Out Myself

I didn't write this from the sidelines. I ran both experiments on my own body, and they're a big part of why I dug into this research.

My total testosterone came back below 300 ng/dL, with the full symptom list to match. Worth flagging against what I wrote above: a formal diagnosis of testosterone deficiency wants symptoms plus consistently low levels across at least two early-morning fasting draws, so treat this as my clinical picture rather than a textbook workup. I started on a TRT protocol, and the cognitive benefits were real. The fog thinned out and the drive came back. But my blood work turned the wrong way fast, faster than I was willing to ride out, so I came off it.

Enclomiphene was the logical next move, for all the reasons above. I wanted to keep my own system running rather than override it. Then I drew the one side effect I just described. My liver enzymes climbed into the range that raises hepatitis concerns, and I wasn't about to trade brain fog for a liver problem, so I cut it too. The clinical guidance says to stop when enzymes climb that high, and that's exactly what I did.

That sent me looking for a third path: raising my testosterone without injections and without hormone drugs. It worked. I took it from below 300 to comfortably over 400 on lifestyle alone. That's a full story of its own, and it's the next article.

Assessment

Let me put this where the evidence actually supports it, because the overclaimed version of this article writes itself and it would not survive an endocrinologist reading it.

The claim I can defend: persistent symptoms after TBI overlap with pituitary hormone deficiency, that deficiency is common enough to be worth ruling out, and most people are never evaluated for it. Chronic hypopituitarism runs around 27.5% pooled after TBI and higher after severe injury. Former NFL players reporting more concussion symptoms report low-testosterone indicators at markedly higher rates, and 60% of them are on nothing for it.

The claim I cannot defend, and won't: that TRT treats brain injury. There is one small randomized trial in TBI, it missed its primary endpoint, and the systematic review covering it says the evidence is too limited to draw conclusions. Anyone selling testosterone as a post-concussion protocol is well out in front of the data.

The distinction is the whole article. A confirmed endocrine deficiency can often be treated, and treating it may lift a contributor that would otherwise stay hidden. That is not the same as treating the injury, and it does not mean every case of fatigue and brain fog is hormonal. Plenty of post-concussion symptoms are exactly what they look like.

So: if you played contact sports and you're dealing with persistent fatigue, fog, depression, or physical decline that hasn't moved no matter what you try, raise it with a clinician and ask whether a pituitary evaluation is appropriate for your history. Not a self-ordered testosterone panel. The right panel depends on your injury, your symptoms, and how long it's been, and it should look at more than testosterone.

The brain fog you've been told to live with might have a contributor nobody has looked for. That is worth one conversation and one blood draw to find out.